Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Raymond See‐Kit Lo"'
Autor:
Hidenori Arai, Keisuke Maeda, Hidetaka Wakabayashi, Tateaki Naito, Masaaki Konishi, Prasert Assantachai, Wai Tung Auyeung, Chalobol Chalermsri, Wei Chen, Justin Chew, Ming‐Yueh Chou, Chih‐Cheng Hsu, Allyn Hum, In Gyu Hwang, Toshimi Kaido, Lin Kang, Shahrul Bahyah Kamaruzzaman, Miji Kim, Jenny Shun Wah Lee, Wei‐Ju Lee, Chih‐Kuang Liang, Wee Shiong Lim, Jae‐Young Lim, Yen Peng Lim, Raymond See‐Kit Lo, Terence Ong, Wen‐Harn Pan, Li‐Ning Peng, Pornpoj Pramyothin, Nurul Huda Razalli, Masakazu Saitoh, Suzana Shahar, Han Ping Shi, Heng‐Hsin Tung, Yasuhito Uezono, Stephan vonHaehling, Chang Won Won, Jean Woo, Liang‐Kung Chen
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 14, Iss 5, Pp 1949-1958 (2023)
Abstract Chronic diseases often lead to metabolic disorders, causing anabolic resistance and increased energy consumption, which result in cachexia. Cachexia, in turn, can lead to major clinical consequences such as impaired quality of life, shortene
Externí odkaz:
https://doaj.org/article/53bd981485d042568bd1471bb4f7009e
Autor:
Alex Molassiotis, Teresa Brown, Hui Lin Cheng, Angela Byrnes, Raymond Javan Chan, David Wyld, Melissa Eastgate, Patsy Yates, Andrea P Marshall, Rebecca Fichera, Liz Isenring, Ki Fung To, Po Shan Ko, Wang Lam, Yuk Fong Lam, Lai Fan Au, Raymond See-kit Lo
Publikováno v:
Nutrition Journal, Vol 20, Iss 1, Pp 1-15 (2021)
Abstract Background Malnutrition in advanced cancer patients is common but limited and inconclusive data exists on the effectiveness of nutrition interventions. Feasibility and acceptability of a novel family-based nutritional psychosocial interventi
Externí odkaz:
https://doaj.org/article/282ba07723e24dc1ade8d21cd36d9321
Autor:
Kwok Ying Chan, Thomas Sau Yan Chan, Harinder Gill, Timmy Chi Wing Chan, Cho Wing Li, Ho Yan Au, Chi Yan Wong, Kwok Wai Tsang, Raymond See Kit Lo, Benjamin Hon Wai Cheng, Chun Him Hui, Lesley Wan Sze Mok, Cecilia Sze Lai Kwok, Man Lui Chan, Mau Kwong Sham
Publikováno v:
Annals of palliative medicine. 11(10)
Recent advances have led to cure or long-term disease control for patients with hematological malignancy (HM). Unfortunately, some of them still have poor prognoses and are often associated with significant symptom burden and poor quality of life for